K A Krolick

Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.

K A Krolick, C. L. Villemez, Peter C. Isakson et al. · Proceedings of the National Academy of Sciences · 1980 · 167 citations · Full text

Pharmacy, Immunology, Oncology +13

In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.

K A Krolick, J W Uhr, Shimon Slavin et al. · The Journal of Experimental Medicine · 1982 · 121 citations · Full text

Medicine, Immunology, Oncology +10

Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes

A J Infante, Patricia A. Thompson, K A Krolick et al. · The Journal of Immunology · 1991 · 55 citations

Life Sciences, Immunology, Pathobiology +17

The effect of anti-immunoglobulin antibodies on the <i>in vitro</i> proliferation and differentiation of normal and neoplastic murineB cells.

Peter C. Isakson, K A Krolick, J W Uhr et al. · The Journal of Immunology · 1980 · 52 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Murine B Cell Leukemia (BCL1): Organ Distribution and Kinetics of Growth as Determined by Fluorescence Analysis with an Anti-Idiotypic Antibody

K A Krolick, Peter C. Isakson, J W Uhr et al. · The Journal of Immunology · 1979 · 42 citations

Life Sciences, Immunology, Oncology +13